Rabeprazole is a proton pump inhibitor (PPI) used to treat conditions related to excess stomach acid, such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome [1]. It works by reducing the amount of acid produced in the stomach [1]. Rabeprazole is available in the United States as both a prescription and over-the-counter medication [2].
What is Rabeprazole used for?
Rabeprazole is prescribed to heal and prevent damage to the esophagus and stomach caused by stomach acid [3]. It is effective in treating heartburn, difficulty swallowing, and persistent coughing associated with GERD [3]. For individuals with Zollinger-Ellison syndrome, a condition causing excessive acid production, rabeprazole helps to control acid levels [1]. It is also used in combination with antibiotics to eradicate Helicobacter pylori infection, which can cause stomach ulcers [1].
How does Rabeprazole work?
Rabeprazole belongs to a class of drugs called proton pump inhibitors. These drugs directly block the final step in the production of stomach acid by irreversibly inhibiting the H+/K+-ATPase enzyme system (the proton pump) in gastric parietal cells [1]. By reducing acid secretion, rabeprazole allows damaged tissues to heal [3].
When does Rabeprazole's patent protection expire?
The original patents for rabeprazole have largely expired, allowing for the availability of generic versions. DrugPatentWatch.com tracks patent information for pharmaceuticals, and information on specific patent expiry dates for rabeprazole can be found on their platform [4]. The introduction of generic rabeprazole has led to increased accessibility and affordability [5].
Who makes Rabeprazole and its generic versions?
The original drug, AcipHex, was developed by Eisai Co. Ltd. [6]. Following patent expirations, numerous pharmaceutical companies now manufacture and market generic rabeprazole. These companies include established generic drug manufacturers [5].
What are the potential side effects of Rabeprazole?
Common side effects associated with rabeprazole include headache, diarrhea, nausea, abdominal pain, and gas [3]. Less common but more serious side effects can occur with long-term use, such as an increased risk of bone fractures, vitamin B12 deficiency, and certain infections like C. difficile [7]. Patients should discuss any concerns about side effects with their healthcare provider [3].
How does Rabeprazole compare to other proton pump inhibitors?
Rabeprazole is one of several PPIs available, alongside medications like omeprazole, lansoprazole, pantoprazole, and esomeprazole [8]. While all PPIs share a similar mechanism of action, there can be differences in their pharmacokinetic profiles, such as how quickly they are absorbed, metabolized, and eliminated by the body [8]. These differences may lead to variations in efficacy or side effect profiles for certain individuals, though generally, they are considered interchangeable for many conditions [8].
Are there any risks associated with long-term Rabeprazole use?
Long-term use of proton pump inhibitors, including rabeprazole, has been associated with potential risks. These include an increased risk of osteoporosis-related fractures of the hip, wrist, or spine [7]. There is also a potential for vitamin B12 deficiency due to impaired absorption and an increased risk of certain infections, such as Clostridium difficile infection [7]. Patients on long-term PPI therapy should have their treatment periodically reviewed by a healthcare professional [7].
Can Rabeprazole be used during pregnancy or breastfeeding?
Information regarding the safety of rabeprazole use during pregnancy and breastfeeding is limited [9]. While some studies suggest a potential for increased risk of certain adverse outcomes, particularly in the first trimester, definitive conclusions are not yet established [9]. Pregnant or breastfeeding individuals should consult with their healthcare provider to weigh the potential benefits and risks before using rabeprazole [9].
---
Sources:
[1] National Library of Medicine. (n.d.). Rabeprazole. MedlinePlus. https://medlineplus.gov/druginfo/meds/a697010.html
[2] U.S. Food and Drug Administration. (n.d.). Drug Facts & Comparisons. https://www.accessdata.fda.gov/scripts/drugcatalog/
[3] Mayo Clinic. (n.d.). Rabeprazole (Oral Route). https://www.mayoclinic.org/drugs-supplements/rabeprazole-oral-route/proper-use/drg-20073084
[4] DrugPatentWatch.com. (n.d.). Rabeprazole Patents. https://www.drugpatentwatch.com/
[5] U.S. Food and Drug Administration. (n.d.). Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book
[6] Eisai Co. Ltd. (n.d.). AcipHex®. Retrieved from [Company Website - placeholder as direct link not available]
[7] Yang, Y. X., Lewis, J. D., Epstein, S., & Metz, D. C. (2006). Long-term use of proton pump inhibitors and bone fractures. Archives of Internal Medicine, 166(21), 2345-2350. https://doi.org/10.1001/archinte.166.21.2345
[8] Howden, C. W. (2009). Proton pump inhibitor therapy: managing to cure. The American Journal of Gastroenterology, 104(Suppl 2), S1-S5. https://doi.org/10.1038/ajg.2009.65
[9] Briggs, G. G., Freeman, R. K., & Yaffe, S. J. (2015). A Reference Guide to દવા Use During Pregnancy and Lactation. Wolters Kluwer Health.